127 related articles for article (PubMed ID: 8943149)
21. Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons.
Monaco EA; Beaman-Hall CM; Mathur A; Vallano ML
Biochem Pharmacol; 2004 May; 67(10):1947-64. PubMed ID: 15130771
[TBL] [Abstract][Full Text] [Related]
22. Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases.
Longshaw VM; Chapple JP; Balda MS; Cheetham ME; Blatch GL
J Cell Sci; 2004 Feb; 117(Pt 5):701-10. PubMed ID: 14754904
[TBL] [Abstract][Full Text] [Related]
23. Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo.
Moreau JL; Marques F; Barakat A; Schatt P; Lozano JC; Peaucellier G; Picard A; Genevière AM
Dev Biol; 1998 Aug; 200(2):182-97. PubMed ID: 9705226
[TBL] [Abstract][Full Text] [Related]
24. Molecular models of protein kinase 6 from Plasmodium falciparum.
Manhani KK; Arcuri HA; da Silveira NJ; Uchôa HB; de Azevedo WF; Canduri F
J Mol Model; 2005 Dec; 12(1):42-8. PubMed ID: 16096806
[TBL] [Abstract][Full Text] [Related]
25. Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinases.
Woodard CL; Li Z; Kathcart AK; Terrell J; Gerena L; Lopez-Sanchez M; Kyle DE; Bhattacharjee AK; Nichols DA; Ellis W; Prigge ST; Geyer JA; Waters NC
J Med Chem; 2003 Aug; 46(18):3877-82. PubMed ID: 12930149
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum.
Harmse L; van Zyl R; Gray N; Schultz P; Leclerc S; Meijer L; Doerig C; Havlik I
Biochem Pharmacol; 2001 Aug; 62(3):341-8. PubMed ID: 11434907
[TBL] [Abstract][Full Text] [Related]
27. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
Motwani M; Li X; Schwartz GK
Clin Cancer Res; 2000 Mar; 6(3):924-32. PubMed ID: 10741717
[TBL] [Abstract][Full Text] [Related]
28. Identification of an effector protein and gain-of-function mutants that activate Pfmrk, a malarial cyclin-dependent protein kinase.
Chen Y; Jirage D; Caridha D; Kathcart AK; Cortes EA; Dennull RA; Geyer JA; Prigge ST; Waters NC
Mol Biochem Parasitol; 2006 Sep; 149(1):48-57. PubMed ID: 16737745
[TBL] [Abstract][Full Text] [Related]
29. Flavopiridol potently induces small cell lung cancer apoptosis during S phase in a manner that involves early mitochondrial dysfunction.
Litz J; Carlson P; Warshamana-Greene GS; Grant S; Krystal GW
Clin Cancer Res; 2003 Oct; 9(12):4586-94. PubMed ID: 14555534
[TBL] [Abstract][Full Text] [Related]
30. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
David-Pfeuty T
Oncogene; 1999 Dec; 18(52):7409-22. PubMed ID: 10602500
[TBL] [Abstract][Full Text] [Related]
31. DNA replication and daughter cell budding are not tightly linked in the protozoan parasite Toxoplasma gondii.
Shaw MK; Roos DS; Tilney LG
Microbes Infect; 2001 Apr; 3(5):351-62. PubMed ID: 11369271
[TBL] [Abstract][Full Text] [Related]
32. cAMP-dependent protein kinase from Plasmodium falciparum: an update.
Wurtz N; Chapus C; Desplans J; Parzy D
Parasitology; 2011 Jan; 138(1):1-25. PubMed ID: 20663247
[TBL] [Abstract][Full Text] [Related]
33. Effect of sinefungin on macromolecular biosynthesis and cell cycle of Plasmodium falciparum.
Messika E; Golenser J; Abu-Elheiga L; Robert-Gero M; Lederer E; Bachrach U
Trop Med Parasitol; 1990 Sep; 41(3):273-8. PubMed ID: 2255844
[TBL] [Abstract][Full Text] [Related]
34. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS
J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase homologues of Plasmodium falciparum.
Doerig C; Endicott J; Chakrabarti D
Int J Parasitol; 2002 Dec; 32(13):1575-85. PubMed ID: 12435442
[TBL] [Abstract][Full Text] [Related]
36. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
Havlícek L; Hanus J; Veselý J; Leclerc S; Meijer L; Shaw G; Strnad M
J Med Chem; 1997 Feb; 40(4):408-12. PubMed ID: 9046330
[TBL] [Abstract][Full Text] [Related]
37. Evidence for CRK3 participation in the cell division cycle of Trypanosoma cruzi.
Santori MI; Laría S; Gómez EB; Espinosa I; Galanti N; Téllez-Iñón MT
Mol Biochem Parasitol; 2002 May; 121(2):225-32. PubMed ID: 12034456
[TBL] [Abstract][Full Text] [Related]
38. Effects of cyclin-dependent kinase inhibitor Purvalanol B application on protein expression and developmental progression in intra-erythrocytic Plasmodium falciparum parasites.
Bullard KM; Broccardo C; Keenan SM
Malar J; 2015 Apr; 14():147. PubMed ID: 25879664
[TBL] [Abstract][Full Text] [Related]
39. A Plasmodium falciparum protein kinase with two unusually large kinase inserts.
Kappes B; Yang J; Suetterlin BW; Rathgeb-Szabo K; Lindt MJ; Franklin RM
Mol Biochem Parasitol; 1995 Jun; 72(1-2):163-78. PubMed ID: 8538687
[TBL] [Abstract][Full Text] [Related]
40. Differential response of the human cyclin B1 promoter to inhibitors of the cell cycle in NIH3T3 cells.
Nuckolls FJ; Khan AS; Butler R; Katula KS
Biochem Biophys Res Commun; 1998 Mar; 244(1):280-4. PubMed ID: 9514874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]